News:

This week IPhone 15 Pro winner is karn
You can be too a winner! Become the top poster of the week and win valuable prizes.  More details are You are not allowed to view links. Register or Login 

Main Menu

India board rules against Bayer in cancer drug patent case

Started by riky, March 05, 2013, 09:00:14 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

riky

India board rules against Bayer in cancer drug patent case

<p><a href="http://news.yahoo.com/india-board-rules-against-bayer-cancer-drug-patent-143949705--business.html"><img src="http://l2.yimg.com/bt/api/res/1.2/GIlhWmXXP8Xy6cWUGVANaQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-03-04T143949Z_1_CBRE92314QH00_RTROPTP_2_INDIA-DRUGS-ANALYSIS.JPG" width="130" height="86" alt="A private security guard looks out from a window of the head office of Natco in the southern Indian city of Hyderabad" align="left" title="A private security guard looks out from a window of the head office of Natco in the southern Indian city of Hyderabad" border="0" /></a>CHENNAI (Reuters) - An Indian patent appeals board upheld on Monday a decision to allow a domestic company to sell a generic version of Bayer AG's cancer drug Nexavar, in a blow for global drugmakers' efforts to hold on to monopolies on high-price medicines. The ruling paves the way for the issue of more so-called compulsory licenses as governments, particularly in emerging markets such as China and Thailand, battle to bring down healthcare costs and provide access to affordable drugs to treat diseases such as cancer, HIV-AIDS and hepatitis. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login
You are not allowed to view links. Register or Login